{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T04:51:48Z","timestamp":1686545508827},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:00:00Z","timestamp":1425945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00246-015-1136-2","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T14:12:07Z","timestamp":1425910327000},"page":"1159-1165","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance"],"prefix":"10.1007","volume":"36","author":[{"given":"Miyu","family":"Tajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,10]]},"reference":[{"issue":"2","key":"1136_CR1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1442-200x.2005.02033.x","volume":"47","author":"M Ayusawa","year":"2005","unstructured":"Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K (2005) Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int Off J Jpn Pediatr Soc 47(2):232\u2013234. doi: 10.1111\/j.1442-200x.2005.02033.x","journal-title":"Pediatr Int Off J Jpn Pediatr Soc"},{"issue":"9","key":"1136_CR2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/INF.0b013e31825c4d7c","volume":"31","author":"LS Callinan","year":"2012","unstructured":"Callinan LS, Tabnak F, Holman RC, Maddox RA, Kim JJ, Schonberger LB, Vugia DJ, Belay ED (2012) Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J 31(9):894\u2013898. doi: 10.1097\/INF.0b013e31825c4d7c","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"1136_CR3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/HCO.0b013e3283588f06","volume":"27","author":"LB Daniels","year":"2012","unstructured":"Daniels LB, Gordon JB, Burns JC (2012) Kawasaki disease: late cardiovascular sequelae. Curr Opin Cardiol 27(6):572\u2013577. doi: 10.1097\/HCO.0b013e3283588f06","journal-title":"Curr Opin Cardiol"},{"issue":"2","key":"1136_CR4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00246-002-0216-2","volume":"24","author":"K Durongpisitkul","year":"2003","unstructured":"Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24(2):145\u2013148. doi: 10.1007\/s00246-002-0216-2","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"1136_CR5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","volume":"149","author":"K Egami","year":"2006","unstructured":"Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149(2):237\u2013240. doi: 10.1016\/j.jpeds.2006.03.050","journal-title":"J Pediatr"},{"key":"1136_CR6","doi-asserted-by":"crossref","first-page":"645391","DOI":"10.1155\/2013\/645391","volume":"2013","author":"N Jamieson","year":"2013","unstructured":"Jamieson N, Singh-Grewal D (2013) Kawasaki disease: a clinician\u2019s update. Int J Pediatr 2013:645391. doi: 10.1155\/2013\/645391","journal-title":"Int J Pediatr"},{"issue":"22","key":"1136_CR7","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Morikawa A (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113(22):2606\u20132612. doi: 10.1161\/CIRCULATIONAHA.105.592865","journal-title":"Circulation"},{"issue":"9826","key":"1136_CR8","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","volume":"379","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, Seki M, Fukazawa R, Ogawa C, Furuno K, Tokunaga H, Takatsuki S, Hara S, Morikawa A (2012) Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 379(9826):1613\u20131620. doi: 10.1016\/S0140-6736(11)61930-2","journal-title":"Lancet"},{"issue":"1","key":"1136_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pedneo.2011.11.003","volume":"53","author":"HC Kuo","year":"2012","unstructured":"Kuo HC, Yang KD, Chang WC, Ger LP, Hsieh KS (2012) Kawasaki disease: an update on diagnosis and treatment. Pediatr Neonatol 53(1):4\u201311. doi: 10.1016\/j.pedneo.2011.11.003","journal-title":"Pediatr Neonatol"},{"issue":"8","key":"1136_CR10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/11631440-000000000-00000","volume":"72","author":"NJ Luca","year":"2012","unstructured":"Luca NJ, Yeung RS (2012) Epidemiology and management of Kawasaki disease. Drugs 72(8):1029\u20131038. doi: 10.2165\/11631440-000000000-00000","journal-title":"Drugs"},{"issue":"625","key":"1136_CR11","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.3399\/bjgp14X680953","volume":"64","author":"A Moore","year":"2014","unstructured":"Moore A, Harnden A, Mayon-White R (2014) Recognising Kawasaki disease in UK primary care: a descriptive study using the clinical practice research datalink. Br J Gen Pract J R Coll Gen Pract 64(625):e477\u2013e483. doi: 10.3399\/bjgp14X680953","journal-title":"Br J Gen Pract J R Coll Gen Pract"},{"issue":"4","key":"1136_CR12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3899\/jrheum.110877","volume":"39","author":"M Mori","year":"2012","unstructured":"Mori M, Imagawa T, Hara R, Kikuchi M, Hara T, Nozawa T, Miyamae T, Yokota S (2012) Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series. J Rheumatol 39(4):864\u2013867. doi: 10.3899\/jrheum.110877","journal-title":"J Rheumatol"},{"issue":"6","key":"1136_CR13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2188\/jea.JE20130048","volume":"23","author":"Y Nakamura","year":"2013","unstructured":"Nakamura Y, Aso E, Yashiro M, Tsuboi S, Kojo T, Aoyama Y, Kotani K, Uehara R, Yanagawa H (2013) Mortality among Japanese with a history of Kawasaki disease: results at the end of 2009. J Epidemiol 23(6):429\u2013434","journal-title":"J Epidemiol"},{"issue":"17","key":"1136_CR14","first-page":"2747","volume":"110","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young. Am Heart Assoc Circ 110(17):2747\u20132771. doi: 10.1161\/01.CIR.0000145143.19711.78","journal-title":"Am Heart Assoc Circ"},{"issue":"10","key":"1136_CR15","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1097\/INF.0b013e31829dd45e","volume":"32","author":"Y Ruan","year":"2013","unstructured":"Ruan Y, Ye B, Zhao X (2013) Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China. Pediatr Infect Dis J 32(10):e397\u2013e402. doi: 10.1097\/INF.0b013e31829dd45e","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"1136_CR16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","volume":"166","author":"T Sano","year":"2007","unstructured":"Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Hara J (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166(2):131\u2013137. doi: 10.1007\/s00431-006-0223-z","journal-title":"Eur J Pediatr"},{"issue":"2","key":"1136_CR17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/1756-185X.12082","volume":"16","author":"S Sato","year":"2013","unstructured":"Sato S, Kawashima H, Kashiwagi Y, Hoshika A (2013) Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients. Int J Rheum Dis 16(2):168\u2013172. doi: 10.1111\/1756-185X.12082","journal-title":"Int J Rheum Dis"},{"issue":"25","key":"1136_CR18","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1161\/CIRCULATIONAHA.107.749515","volume":"118","author":"H Senzaki","year":"2008","unstructured":"Senzaki H (2008) Long-term outcome of Kawasaki disease. Circulation 118(25):2763\u20132772. doi: 10.1161\/CIRCULATIONAHA.107.749515","journal-title":"Circulation"},{"issue":"9","key":"1136_CR19","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1097\/INF.0b013e3182952027","volume":"32","author":"Y Shiozawa","year":"2013","unstructured":"Shiozawa Y, Inuzuka R, Harita Y, Kagawa J (2013) Age-related differences in the course of the acute phase symptoms of Kawasaki disease. Pediatr Infect Dis J 32(9):e365\u2013e369. doi: 10.1097\/INF.0b013e3182952027","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"1136_CR20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1442-200X.2010.03161.x","volume":"52","author":"D Sudo","year":"2010","unstructured":"Sudo D, Monobe Y, Yashiro M, Sadakane A, Uehara R, Nakamura Y (2010) Case\u2013control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey. Pediatr Int Off J Jpn Pediatr Soc 52(5):790\u2013794. doi: 10.1111\/j.1442-200X.2010.03161.x","journal-title":"Pediatr Int Off J Jpn Pediatr Soc"},{"issue":"3","key":"1136_CR21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3400\/avd.sasvp01003","volume":"3","author":"K Takahashi","year":"2010","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y, Hiruta N, Naoe S (2010) Kawasaki disease as a systemic vasculitis in childhood. Ann Vasc Dis 3(3):173\u2013181. doi: 10.3400\/avd.sasvp01003","journal-title":"Ann Vasc Dis"},{"issue":"1","key":"1136_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/BOR.0000000000000010","volume":"26","author":"K Takahashi","year":"2014","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y (2014) Update on etio and immunopathogenesis of Kawasaki disease. Curr Opin Rheumatol 26(1):31\u201336. doi: 10.1097\/BOR.0000000000000010","journal-title":"Curr Opin Rheumatol"},{"issue":"9930","key":"1136_CR23","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(13)62298-9","volume":"383","author":"AH Tremoulet","year":"2014","unstructured":"Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC (2014) Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet 383(9930):1731\u20131738. doi: 10.1016\/S0140-6736(13)62298-9","journal-title":"Lancet"},{"issue":"3","key":"1136_CR24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/art.37815","volume":"65","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y (2013) Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1\/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis Rheum 65(3):805\u2013814. doi: 10.1002\/art.37815","journal-title":"Arthritis Rheum"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-015-1136-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-015-1136-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-015-1136-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T14:18:38Z","timestamp":1558707518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-015-1136-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,10]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1136"],"URL":"https:\/\/doi.org\/10.1007\/s00246-015-1136-2","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,10]]}}}